chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been recived concerning a 6 year old white male who on 08/02/96 was vaccinated with varicella virus vaccine live. On 11/21/00, the patient experience breakthrough varicella. On 11/29/00, the patient recovered from breakthrough varicella. Other patients were reported with similar symptoms following varicella virus vaccine live (WAES 01072609-01072610, 01072612-01072617, 01030289, 0107217, 01072719). no further information is available.
Swollen lymph nodes on the left side of my face near my periauricular pit in my ear. This pit has been leaking fluid since 7:00 AM yesterday, on April 2. There is a mild, numbing pain in the region, and I've taken Ibuprofin to deal with that pain.    I don't know how long this will last, but according to the handout I got, swollen lymph nodes are normal and I had no other adverse side effects other than feeling a bit drowsy this morning, though me staying up until 3:00 AM playing video games could be a confounding effect.
I developed DVT and a pulmonary embolism and had to have a thrombectomy. I was transferred to the hospital locally. And then I had my surgery in another HCF.
Sluggish on the night of the vaccine, during the night chills, extreme tired and shooting paing in my hand.  next day completely spend day in bed was extreme tired, no appetite food has no taste and was very sluggish.  The next day I was totally fine only lasted about 24 to 36 hours.
Starting 12 hours after shot ran high fever, chills, body aches, stomach problems, diarrhea, fatigue, sharp pains throughout body, bad headaches cough
Narrative:  Patient discharged to home after hospitalization x 13 days. Discharged with oxygen.
the patient was so excited after the first shot of the Covid-19 vaccine; This is a spontaneous report from a contactable consumer or other non hcp. A 80-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: Unknown) via an unspecified route of administration in left arm on 12Jan2021 (age at vaccination 80-year-old) as 1st dose, single for Covid-19 immunisation. Patients medical history included stent placement from 2005, put in 5 stents, caller reported that the patient had a stent placed in his neck in nov2019, heart attack from 2017, sensitivity to bug bites if the patient went outside and got a mosquito bites, he looked like he had been beat with the knots on him, hypertension, contrast media allergy from 2005, high blood pressure and reaction to contrast dye on 2005. Concomitant medication included cetirizine taken for allergy problem, amlodipine besilate taken for hypertension, aspirin [acetylsalicylic acid] taken for antiplatelet therapy. The patient previously took codeine and experienced drug intolerance. Patient have sensitivity to codeine, goes way back, 40-50 years. The patient previously took tetanus vaccine, 20 years ago at least. The patient was so excited after the first shot of the covid-19 vaccine. The patient underwent lab tests and procedures which included x-ray: normal on 04Apr2021. The outcome of event was unknown.  Information on the lot/batch number has been requested.
Racing heart; pulse rate of 154; fever of 101.4; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A 60-year-old female patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 60 years for covid-19 immunisation. The patient's relevant medical history included: "breast cancer" (unspecified if ongoing), notes: Survivor of breast cancer and letrosole patient. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 3, Pfizer Covid vaccine), for Covid-19 Immunization; Bnt162b2 (Dose: 2, Pfizer Covid vaccine), for Covid-19 Immunization; Bnt162b2 (Dose:1, Pfizer Covid vaccine), for Covid-19 Immunization. The following information was reported: PALPITATIONS (non-serious), outcome "unknown", described as "Racing heart"; HEART RATE INCREASED (non-serious), outcome "unknown", described as "pulse rate of 154"; PYREXIA (non-serious), outcome "unknown", described as "fever of 101.4". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Description of Event: Racing heart, Pulse rate of 154, Fever of 101.4. Survivor of breast cancer and letrosole patient. Optional Information: Breast cancer survivor, Pfizer Covid vaccine from first dose to 2nd booster. Event took place after use of product.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
After getting the injection a red mark appeared; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious) with onset 2021, outcome "unknown", described as "After getting the injection a red mark appeared".  Additional Information: Caller got her 1st dose last week and after getting the injection a red mark appeared and she wanted to know why that would disappear. She stated it was not bothering her at all.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Difficulty regulating body temperature since 1/8/21. Intermittent and difficult to relieve chills and soaking night sweats.
Joints swelled, hurt to move. Could not walk without assistance. Could not bend. Hot and then cold chills. Felt sick all over. No treatment, waited for this to pass
10 to 14 days post vax, the pt developed hives on her hands, arms, forehead, legs, and around her ears.
This is a spontaneous report obtained from a contactable consumer. A 17 year old male patient received, on 03Mar2016, TRUMENBA (Lot. M95612, Expiration date: Dec2016, NDC number: 00005-0100-05) intramuscular, in the left arm, at single dose. The vaccine was received at the doctor office. Relevant medical history included bronchitis. Concomitant medications included doxycycline, CLARINEX and NASACORT. On an unspecified date, the patient experienced reduction of arm movements, pain in left armpit, swelling in armpit and left pectoral muscle, muscle pain issues, and temperature elevation (he had temperature of 99.3 degrees Fahrenheit). Treatment was received (ibuprofen and acetaminophen). The patient did not recover from the events at time of this report. Follow (01MAY2016): Follow-up attempts completed. No further information expected.
Patient says she had an increased heart beat & blurred vision She said she is hypoglycemic gave her a coke and she was okay
Next day pain in arm began, two days later went to urgent care with severe pain in left shoulder (bursitis like), 102F fever, body aches, flu-like symptoms, some hives near injection site.
Patient received 0.5ml of Janssen in right deltoid on 5/16/21. He experienced side effects (fever, chills and joint pain) starting that night at 8pm. He reports that his knees hurt so bad that he could not walk. He is treating with tylenol and ibuprofen and side effects have improved
Slight pains in upper left arm; Continues to have soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Slight pains in upper left arm) and MYALGIA (Continues to have soreness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Slight pains in upper left arm) and MYALGIA (Continues to have soreness). At the time of the report, PAIN IN EXTREMITY (Slight pains in upper left arm) and MYALGIA (Continues to have soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported.  No treatment information was reported
Pt recv vax on 4/3/97; on 6/25/97 pt exp Bell's Palsy 3x (6/25/97, 1/15/98, 2/4/99)
I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 7/30/2021 ARTHRITIS OF RIGHT KNEE
Fever of 103.8 for 14 hours, chills, sweating, body aches, non appetite, and headache.
Sweat; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweat) and CHILLS (Chills) in a 78-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Sweat) and CHILLS (Chills). At the time of the report, HYPERHIDROSIS (Sweat) and CHILLS (Chills) outcome was unknown.    No concomitant medications was reported. No treatment drug details was reported. This case was linked to US-MODERNATX, INC.-MOD-2022-647572, US-MODERNATX, INC.-MOD-2022-647571 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-647572:case for patient-1 US-MODERNATX, INC.-MOD-2022-647571:Patient No 2 case
Stiff, swollen, red arm - treated with BENADRYL. Vomiting, chest tightness. Dizziness, fatigue. Fever 101 degrees - treated w/ TYLENOL. Body aches.
Information has been received from a certified medical assistant referring to unspecified number of patients of unknown age. On an unknown date the patients were vaccinated with doses of improperly stored ROTATEQ (dose, lot# were not reported, oral). No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a Licensed Vocational Nurse (LVN) refers to a patient of unknown age and gender. The patient's pertinent medical history and concurrent conditions were not reported. On 17-OCT-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) lot # K012918, Expiry date: 28-FEB-2016 (dose and route not specified). No adverse effects were reported. No further information was provided. This is one of the two reports received from the same reporter. Additional information has been requested.
Mild soreness 8-48 hrs after vaccine. Now, over a week later the injection site is swollen, tender, and itchy.
Patient developed a varicella like blister approximately 2 inches away from injection site. Referred patient to primary care provider for diagnosis and treatment.
Immunizations administered on 9/18 at 1:30pm. Patient came into Pharmacy on 9/20 at 6:20pm to pick-up RX for SMZ-TMP 800-160. Patient's arm was swollen from elbow to middle of upper arm. Area was hot red, swollen, nothing at actual injection site. Pt went to Dr on 9/20. Dr was not sure if from vaccine or not. Gave SMZ-TMP as precaution, also unsure if it was infection.
On March 30 developed numbness on Left arm from shoulder to hand. Seen at ER  for evaluation. Recommendation according to husband was for Physical Therapy.
This spontaneous report was received from an unspecified reporter via an online article published and refers to a 4131 patients of unknown age and gender. The events were reported via Vaccine Adverse Event Reporting System. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with doses of quadrivalent HPV vaccine (manufacturer unknown) (dose, route of administration, anatomical location, lot # and expiration date were not reported). On unknown dates, the patients experienced unspecified adverse events and were hospitalized on unknown dates. The outcome of adverse events was unknown. The relatedness between the events and quadrivalent HPV vaccine (manufacturer unknown) was not reported. This is one of several reports received from the same reporter. Additional information is not expected as no contact details were provided.
swollen arm; Localised feeling of warmth; Vaccination site reaction; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm), VACCINATION SITE REACTION (Vaccination site reaction) and FEELING HOT (Localised feeling of warmth) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis.    The patient's past medical history included Bone spur in 1976, Knee swelling in 2011, Osteoarthritis in January 1996, Knee osteoarthritis in 2014, Osteoarthritis in 2011 and Foot surgery. Concurrent medical conditions included Osteoarthritis (in Nov-2020, knee Osteoarthritis in 2014, in 2011) since November 2020, Walking difficulty since 2011, Discomfort in joints (KNEE DISCOMFORT in 2011), Alcohol use (ALCOHOL USER/BEER AND GLASS OF WINE OCCATIONALLY) since 1976 and Non-tobacco user. Concomitant products included METHOTREXATE for Rheumatoid arthritis, FOLIC ACID for Supplementation therapy, DENOSUMAB (PROLIA) for an unknown indication.   In January 2019, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose every two weeks. On 11-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, the patient experienced PERIPHERAL SWELLING (swollen arm). 11-Apr-2021, the patient experienced FEELING HOT (Localised feeling of warmth). In 2021, the patient experienced VACCINATION SITE REACTION (Vaccination site reaction). On 25-Apr-2021, PERIPHERAL SWELLING (swollen arm) outcome was unknown, FEELING HOT (Localised feeling of warmth) had resolved. At the time of the report, VACCINATION SITE REACTION (Vaccination site reaction) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: came positive for anti-bodies.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       In 2021, the patient experienced bad reaction on left arm at covid vaccination site. On 11-Apr-2021 patient experienced feverish arm and arm got very swollen. On 01-Nov-2021, the patient underwent out patient total right knee replacement surgery with titanium joint. Patient chose not to have the second dose of covid 19 vaccine. It was unknown if patient was enrolled in a COVID-19 vaccine Trial. No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   Most recent FOLLOW-UP information incorporated above includes: On 20-Oct-2021: significant follow up- event added. On 18-Nov-2021: Significant follow up- event added On 20-Dec-2021: Live Significant Follow-up appended
Gastritis; Upset stomach; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  An 83 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 13Feb2021 12:30 (Lot number: CL9264) at the age of 83 years as dose 1, single and intramuscular, administered in arm left, administration date 07Mar2021 10:00 (Lot number: EN6205) as dose 2, single for covid-19 immunisation. Relevant medical history included: "hypothyroid", start date: 1990 (ongoing), notes: Levoxyl; "hyperparathyroidism" (unspecified if ongoing); "replacement" (unspecified if ongoing); "had supraventricular tachycardia", start date: Feb2016 (ongoing), notes: she had supraventricular tachycardia diagnosed four years ago and had an ablation, Cardiac ablation Jan2017; "Osteopenia", start date: 2017 (ongoing), notes: Prolia; "Myofascial pain", start date: 1996 (ongoing), notes: PT cortisone injection; "shoulder pain", start date: 1996 (ongoing), notes: PT cortisone injection; "bursitis", start date: 1996 (ongoing), notes: PT cortisone injection; "Arm pain" (unspecified if ongoing). Concomitant medication(s) included: LEVOXYL taken for hypothyroidism (ongoing); VITAMIN D2; PREMARIN (ongoing); GABAPENTIN taken for neuropathy peripheral (ongoing); VOLTAREN [DICLOFENAC DIETHYLAMINE] taken for neuropathy peripheral (ongoing); CBD COMPLEX taken for neuropathy peripheral (ongoing); CALCIUM CITRATE (ongoing); MAGNESIUM (ongoing); PROLIA taken for osteopenia; CORTISONE taken for myofascial pain syndrome, arthralgia, bursitis. The following information was reported: ABDOMINAL DISCOMFORT (non-serious) with onset Mar2021, outcome "not recovered", described as "Upset stomach"; GASTRITIS (non-serious) with onset 16Mar2021, outcome "recovered" (Sep2021), described as "Gastritis". The event "gastritis" was evaluated at the physician office visit. Therapeutic measures were taken as a result of gastritis: GI workup Omeprazole 10 mg BID- Sep2021.  No follow-up attempts are possible. No further information is expected.
dizzy; light-headed; bad headache; This is a spontaneous report from a contactable consumer.  A 41-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Lot number: unknown), via an unspecified route of administration, administered in left arm on 05Feb2021 at 03:45 (at the age 41-years-old) as unknown single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Patient did not receive any other medication within 2 weeks prior to the COVID-19 vaccine. The patient had not been tested for COVID-19 nor before neither since the vaccination. Patient did not have allergies. No other medical and concomitant medication history were reported. On 05Feb2021 about 2 to 3 hours after receiving the vaccine, patient became very dizzy and light-headed and got a very bad headache. Patient went to bed, slept about 10 hours and got up feeling fine the next morning. The event was not treated. The outcome of the events were recovered on 06Feb2021.   Follow-up attempts completed. No further information expected.
13 days after the Booster, I developed severe itching , Chronic Spontaneous Urticaria, with no known cause. As well as Dermatographism.  Taking allergy medications such as Zyrtec, Clariton and Benadryl. Nothing has helped. It has been almost a week so far, but after much research I have come to find many others are suffering from this as well.
was at room temperature for 48 hours was administered; administration from expired vial; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administration from expired vial) and PRODUCT STORAGE ERROR (was at room temperature for 48 hours was administered) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 078J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administration from expired vial). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (was at room temperature for 48 hours was administered). On 06-Jan-2022, EXPIRED PRODUCT ADMINISTERED (administration from expired vial) had resolved. At the time of the report, PRODUCT STORAGE ERROR (was at room temperature for 48 hours was administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications and treatment information were not provided by reporter.
SIDS on death certificate; not reported by family-PHN remembered giving vax;  no known SE from vax;
Information has been received from a health department employee concerning a male child patient who on an unspecified date was vaccinated with the second dose of VARIVAX (Merck). After vaccination the patient experienced shingles. The patient sought unspecified medical attention. At the time of report the patient's status was unknown. Additional information has been requested.
lightheaded, achy felt lousy-almost immed home ill from work 25OCT96 afeb;soreness @ inj site lt arm x 1wk;
Information has been received from a pharmacist concerning a 68 year old male with hypertension, hypercholesterolaemia and asthma who was in patient at the hospital for 24 hour observation, due to other health care related problems (chest pains, cardiac workup). Before being discharged on 29-DEC-2010 the patient was vaccinated with a subcutaneous PNEUMOVAX 23 in the abdomen. Concomitant therapy included MIRAPEX, PLAVIX, NORVASC, montelukast sodium (MSD), LOPRESSOR and corticosteroids (unspecified). In approximately December 2010, the patient's abdomen was red, hot and firm. the erythema went from navel to groin and around to the backside. Patient's primary care physician was contacted and the patient was treated with BENADRYL and ibuprofen as needed. On 03-Jan-2011, patient was better, recovering, but some redness persisted. Additional information has been requested.
5 minutes, post vax, the child broke out in something that appeared to be small welt-like and in about 5 minutes, they began to disappear all over.
Patient with right upper arm redness, starting night of vaccine administration day, patient seen on 12/22/17 with almost complete resolution of possible cellulitis without taking antibiotic prescribed.
couldn't breathe; coughed for 10 days; severely sick; She did not receive the second dose at the scheduled time; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (couldn't breathe), COUGH (coughed for 10 days), ILLNESS (severely sick) and PRODUCT DOSE OMISSION ISSUE (She did not receive the second dose at the scheduled time) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 immunisation.     The patient's past medical history included COVID-19 in November 2020.    In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (couldn't breathe), COUGH (coughed for 10 days), ILLNESS (severely sick) and PRODUCT DOSE OMISSION ISSUE (She did not receive the second dose at the scheduled time). At the time of the report, DYSPNOEA (couldn't breathe), COUGH (coughed for 10 days) and ILLNESS (severely sick) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (She did not receive the second dose at the scheduled time) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No Treatment information was reported.  The patient got COVID in November 2020. She had the antibodies in January 2021. She received the Moderna COVID19 Vaccine in May 2021. Three weeks later, she got severely sick. She almost ended up in the hospital.
pt recv vax 7DEC95 & 7FEB96;one of the vaccinations was administered w/in 3 days of exposure to varicella;1APR96, lab eval revealed a negative titer;no further details were provided;